BREAST & OVARY CANCERS (BOC) The Breast & Ovary Cancers (BOC) Program brings together a highly cross-disciplinary and collaborative group of investigators dedicated to reducing the incidence and mortality of breast and ovary cancers. The program fosters interdisciplinary research at Fred Hutch (FH), University of Washington (UW), Seattle Cancer Care Alliance (SCCA), and in the community to improve cancer prevention, detection, diagnosis, and treatment. The BOC Program is led by Drs. Nancy Davidson and Elizabeth Swisher, along with Associate Program Leaders, Drs. Julie Gralow and Barbara Goff, who are leaders at the institutions described above. The Program aims to (1) improve strategies to assess risk, identify, screen, and prevent breast and ovary cancer in women, especially those at high risk and (2) develop targeted therapies for breast and ovary cancers with a special focus on improving response and predicting resistance. The BOC Program currently has 54 members with 11 based at Fred Hutch and 43 based at University of Washington. The current research support of BOC members is $14.7M (direct costs), of which $8.8M is peer- reviewed funding, including $3.5M from the NCI. BOC Program members published a total of 628 papers over the current grant period, of which 20% were intra-programmatic, 28% were inter-programmatic, and 47% had external co-authors. All 12 Consortium Shared Resources were utilized by BOC members in the course of their work. This P30 grant also assists this program by providing administrative and logistical support for BOC meetings, pilot funding for new research projects, and recruitment resources for new faculty.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Fred Hutchinson Cancer Research Center
United States
Zip Code
Syrjala, Karen L; Yi, Jean C; Artherholt, Samantha B et al. (2018) An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantation. J Cancer Surviv 12:560-570
Hempstead, Bridgette; Green, Cynthia; Briant, Katherine J et al. (2018) Community Empowerment Partners (CEPs): A Breast Health Education Program for African-American Women. J Community Health 43:833-841
OhAinle, Molly; Helms, Louisa; Vermeire, Jolien et al. (2018) A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV. Elife 7:
Liu, Yanyan; Xiong, Sican; Sun, Wei et al. (2018) Joint Analysis of Strain and Parent-of-Origin Effects for Recombinant Inbred Intercrosses Generated from Multiparent Populations with the Collaborative Cross as an Example. G3 (Bethesda) 8:599-605
Liu, Yang; He, Qianchan; Sun, Wei (2018) Association analysis using somatic mutations. PLoS Genet 14:e1007746
Glaser, Adam K; Chen, Ye; Yin, Chengbo et al. (2018) Multidirectional digital scanned light-sheet microscopy enables uniform fluorescence excitation and contrast-enhanced imaging. Sci Rep 8:13878
Du, Jing; Flynn, Ryan; Paz, Katelyn et al. (2018) Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients. Blood 131:1743-1754
Mora-Pinzon, Maria C; Trentham-Dietz, Amy; Gangnon, Ronald E et al. (2018) Urinary Magnesium and Other Elements in Relation to Mammographic Breast Density, a Measure of Breast Cancer Risk. Nutr Cancer 70:441-446
Shirts, Brian H; Konnick, Eric Q; Upham, Sarah et al. (2018) Using Somatic Mutations from Tumors to Classify Variants in Mismatch Repair Genes. Am J Hum Genet 103:19-29
Kuzma, Jessica N; Hagman, Derek K; Cromer, Gail et al. (2018) Intra-individual variation in markers of intestinal permeability and adipose tissue inflammation in healthy normal weight to obese adults. Cancer Epidemiol Biomarkers Prev :

Showing the most recent 10 out of 1267 publications